ACAD
33.79
-0.92
-2.65%
AEMD
2.193
+0.073
+3.4198%
APRI
1.17
+0.01
+0.8534%
ARNA
1.4
+0.01
+0.72%
ATEC
2.01
+0.03
+1.52%
CNAT
8.36
+0.84
+11.17%
CRXM
0.2
0.00
0.00%
CYTX
1.06
0.00
0.00%
DXCM
75.86
+0.92
+1.23%
GNMK
13.06
+0.21
+1.59%
HALO
13.99
+0.03
+0.21%
ILMN
182.97
+1.47
+0.81%
INNV
0.094
+0.001
+0.967%
INO
6.69
-0.1
-1.47%
ISCO
1.75
+0.12
+7.36%
ISIS
57.56
0.00
0.00%
LGND
109.505
+0.605
+0.556%
LPTN
2.93
0.00
0.00%
MBVX
2.07
-0.01
-0.4663%
MEIP
1.54
-0.02
-1.2692%
MNOV
5.92
+0.35
+6.28%
MRTX
4.65
+0.05
+1.09%
MSTX
0.138
+0.002
+1.6260%
NBIX
53.58
-0.04
-0.07%
NUVA
73.56
-3.38
-4.39%
ONCS
1.18
+0.02
+1.72%
ONVO
2.849
+0.069
+2.4928%
OREX
3.19
+0.09
+2.90%
OTIC
13.65
+0.45
+3.41%
QDEL
24.13
-0.37
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
1.475
+0.025
+1.724%
RMD
71.79
+0.85
+1.20%
SPHS
2.588
-0.012
-0.4500%
SRNE
1.975
+0.075
+3.947%
TROV
0.914
+0.037
+4.231%
VICL
2.332
-0.028
-1.1991%
VOLC
18
0.00
0.00%
ZGNX
10.9
+0.1
+0.93%
ACAD
33.79
-0.92
-2.65%
AEMD
2.193
+0.073
+3.4198%
APRI
1.17
+0.01
+0.8534%
ARNA
1.4
+0.01
+0.72%
ATEC
2.01
+0.03
+1.52%
CNAT
8.36
+0.84
+11.17%
CRXM
0.2
0.00
0.00%
CYTX
1.06
0.00
0.00%
DXCM
75.86
+0.92
+1.23%
GNMK
13.06
+0.21
+1.59%
HALO
13.99
+0.03
+0.21%
ILMN
182.97
+1.47
+0.81%
INNV
0.094
+0.001
+0.967%
INO
6.69
-0.1
-1.47%
ISCO
1.75
+0.12
+7.36%
ISIS
57.56
0.00
0.00%
LGND
109.505
+0.605
+0.556%
LPTN
2.93
0.00
0.00%
MBVX
2.07
-0.01
-0.4663%
MEIP
1.54
-0.02
-1.2692%
MNOV
5.92
+0.35
+6.28%
MRTX
4.65
+0.05
+1.09%
MSTX
0.138
+0.002
+1.6260%
NBIX
53.58
-0.04
-0.07%
NUVA
73.56
-3.38
-4.39%
ONCS
1.18
+0.02
+1.72%
ONVO
2.849
+0.069
+2.4928%
OREX
3.19
+0.09
+2.90%
OTIC
13.65
+0.45
+3.41%
QDEL
24.13
-0.37
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
1.475
+0.025
+1.724%
RMD
71.79
+0.85
+1.20%
SPHS
2.588
-0.012
-0.4500%
SRNE
1.975
+0.075
+3.947%
TROV
0.914
+0.037
+4.231%
VICL
2.332
-0.028
-1.1991%
VOLC
18
0.00
0.00%
ZGNX
10.9
+0.1
+0.93%
Home » Events, SDBN Events

SDBN Networking Event Featuring Fate Therapeutics & Stemgent

Submitted by on July 1, 2009 – 11:41 am

The San Diego Biotechnology Network’s July 21st event will feature Fate Therapeutics and Stemgent, two companies engaged in exciting, interdisciplinary biotechnology research in San Diego that holds direct promise for making a difference in our quality of life. Ken Batchelor, Ph.D., CSO, Fate Therapeutics, and Stephen Chang, Ph.D., CSO, Stemgent will present a short talk which will be followed by networking:

CATALYST: The Industrialization of Advanced iPSC Technology for Drug Discovery & Development

For more information visit http://sdbn.org/july

Be Sociable, Share!